Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS)
Journal Title: Annals of Hepatology - Year 2017, Vol 16, Issue 1
Abstract
Introduction and Aim: Hepatic encephalopathy (HE) is a common complication of transjugular intrahepatic portosystemic shunting (TIPS). It is associated with a reduced quality of life and poor prognosis. The aim of this study was to compare two groups of patients who did and did not develop overt HE after TIPS. We looked for differences between these groups before TIPS. Materials and methods: A study of 895 patients was conducted based on a retrospective analysis of clinical data. Data was analyzed using Fisher’s exact test, Chi-square, Mann Whitney test, unpaired t-test and logistic regression. After the initial analyses, we have looked at a regression models for the factors associated with development of HE after TIPS. Results: 257 (37.9%) patients developed HE after TIPS. Patients’ age, pre-TIPS portal venous pressure, serum creatinine, aspartate transaminase, albumin, presence of diabetes mellitus and etiology of portal hypertension were statistically significantly associated with the occurrence of HE after TIPS (p < 0.01). However, only the age, pre-TIPS portal venous pressure, serum creatinine, presence of diabetes mellitus and etiology of portal hypertension contributed to the regression model. Patients age, serum creatinine, presence of diabetes mellitus and portal vein pressure formed the model describing development of HE after TIPS for a subgroup of patients with refractory ascites. Conclusion: we have identified, using a substantial sample, several factors associated with the development of HE after TIPS. This could be helpful in further research.
Authors and Affiliations
Michaela Routhu, Vaclav Safka, Sunil Routhu, Tomas Fejfar, Antonin Krajina, Eva Cermakova, Ladislav Hosak
Keywords
Related Articles
- EP ID EP207249
- DOI -
- Views 96
- Downloads 0
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
Liver biopsy is the recognized gold standard for liver fibrosis staging. The aspartate aminotransferase to platelet ratio index (APRI) has been proposed as a noninvasive and readily available tool for the assessment of l...
Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression
Background and rationale for the study. IL-17, TGF-β1/2 are cytokines involved in the development of kidney, pulmonaryand liver fibrosis. However, their expression kinetics in the pathogenesis of cholestatic liver fibro...
Different models in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure
Background and aims. Effective assessing the prognosis of patients with end-stage liver disease is always challenging. This study aimed to investigate the accuracy of different models in predicting short-ter...
Isolated Intrapulmonary Vascular Dilatations and the Risk of Developing Hepatopulmonary Syndrome in Liver Transplant Candidates
Background. The natural history of intrapulmonary vascular dilations (IPVD) and their impact on patient outcomes in the setting of portal hypertension has only been described in small series. Aims. To assess the developm...
Portopulmonary hypertension: state of the art
Portopulmonary hypertension is an uncommon but treatable pulmonary vascular consequence of portal hypertension, which can lead to significant morbidity and mortality. Portopulmonary hypertension results from excessive pu...